Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 1.6B 165M 144M 133M 125M 233M 15.56B 235M 1.58B 613M 7.67B 620M 606M 26.58B P/E 2026 *
17.5x
P/E 2027 * 35.8x
Enterprise Value 1.36B 140M 122M 113M 106M 198M 13.21B 200M 1.34B 520M 6.51B 526M 515M 22.57B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 2.02x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.64%
Current month-16.37%
1 month-16.37%
3 months-12.59%
6 months+10.75%
Current year-11.71%
1 month 6.18
Extreme 6.18
6.73
Current year 6.18
Extreme 6.18
7.39
1 year 5.15
Extreme 5.15
7.39
3 years 4.32
Extreme 4.32
7.39
5 years 4.21
Extreme 4.21
15.87
10 years 3
Extreme 3
17.57
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Executive Officer - 01/07/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Director TitleAgeSince
Director/Board Member - 01/01/2022
Chairman - 27/09/2023
Director/Board Member - 23/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%0.00% - - 169M
-1.43%-5.88%+39.20%+141.78% 992B
-2.64%-4.34%+51.25%+38.90% 564B
-2.20%-3.80%+16.57%+56.89% 391B
-2.90%+0.68%+24.66%+16.53% 330B
-2.36%-3.12%+24.71%+12.95% 280B
-2.45%-2.88%+24.29%+29.93% 279B
-1.91%-0.87%-41.95%-48.26% 196B
-1.58%-5.24%+15.84%+46.77% 184B
-2.22%-2.54%+13.58%+57.86% 156B
Average -2.13%+0.41%+18.68%+39.26% 374.58B
Weighted average by Cap. -2.19%-0.49%+27.55%+62.40%

Financials

2026 *2027 *
Net sales 658M 67.72M 59M 54.39M 51.16M 95.71M 6.38B 96.38M 647M 251M 3.15B 254M 249M 10.9B 663M 68.23M 59.45M 54.8M 51.55M 96.44M 6.43B 97.11M 652M 253M 3.17B 256M 251M 10.98B
Net income 92.33M 9.5M 8.28M 7.63M 7.18M 13.43M 896M 13.52M 90.8M 35.26M 441M 35.67M 34.9M 1.53B 45M 4.63M 4.04M 3.72M 3.5M 6.55M 436M 6.59M 44.25M 17.19M 215M 17.38M 17.01M 746M
Net Debt -242M -24.9M -21.7M -20M -18.82M -35.2M -2.35B -35.45M -238M -92.42M -1.16B -93.48M -91.48M -4.01B -263M -27.03M -23.55M -21.71M -20.42M -38.21M -2.55B -38.47M -258M -100M -1.26B -101M -99.29M -4.35B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
60.30NOK
Average target price
84.00NOK
Spread / Average Target
+39.30%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!